Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation

Show other versions (1)

Background. According to the some studies tocilizumab therapy (TCZ) in patients with rheumatoid arthritis (RA) is accompanied by deterioration of blood lipid profile. Aim. To study changes in serum lipid parameters in patients with RA treated with a combination of tocilizumab and methotrexate compar...

Full description

Bibliographic Details
Main Authors: E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
Format: Article
Language:English
Published: Столичная издательская компания 2015-11-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
rheumatoid arthritis
tocilizumab
methotrexat
lipids
statins
Online Access:https://www.rpcardio.online/jour/article/view/325

Internet

https://www.rpcardio.online/jour/article/view/325

Similar Items